Feb 26, 2025 | Defective Drugs, Depo-Provera, Multidistrict Litigation, Product Liability
For decades, Depo-Provera has been a widely used injectable contraceptive. It often receives praise for its convenience and long-term effectiveness. However, recent lawsuits are emerging linking Depo-Provera to serious health risks, including the development of...
Nov 19, 2024 | Defective Drugs, Defective Product, Depo-Provera, Product Liability
Depo-Provera, an injectable contraceptive containing the synthetic hormone medroxyprogesterone acetate (MPA), has been widely used for decades as an effective birth control method. While it is valued for its convenience and long-term efficacy, concerns have emerged...
Nov 5, 2024 | Defective Drugs, Defective Product, Depo-Provera, Personal Injury, Product Liability
Depo-Provera, a widely-used injectable contraceptive, has offered a convenient birth control option for millions of women worldwide. Yet, while the drug’s appeal has long rested on its effectiveness and quarterly dosing schedule, serious side effects and long-term...
Aug 6, 2024 | Defective Drugs, Defective Product, Medical News, Product Liability
Tepezza (teprotumumab) has emerged as a groundbreaking treatment for Thyroid Eye Disease (TED), a condition that can cause bulging eyes, double vision, and other serious issues. While Tepezza has offered hope to many patients, it has also raised concerns due to...
Aug 2, 2024 | Defective Drugs, Defective Product, Medical News, Ozempic Injury, Ozempic Lawsuit, Personal Injury
Ozempic (semaglutide) is a prescription medication primarily used to improve blood sugar control in adults with type 2 diabetes. Approved by the U.S. Food and Drug Administration (FDA) in 2017, Ozempic belongs to a class of drugs known as GLP-1 receptor agonists....
